Greenleaf Trust reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 106,348 shares of the company's stock after selling 1,735 shares during the quarter. Greenleaf Trust's holdings in Procter & Gamble were worth $18,124,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the stock. Navigoe LLC bought a new position in shares of Procter & Gamble during the fourth quarter valued at approximately $31,000. Capital A Wealth Management LLC purchased a new stake in shares of Procter & Gamble in the fourth quarter valued at approximately $31,000. Hoey Investments Inc. boosted its holdings in shares of Procter & Gamble by 321.7% in the fourth quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after purchasing an additional 148 shares during the period. LFA Lugano Financial Advisors SA purchased a new stake in shares of Procter & Gamble in the fourth quarter valued at approximately $34,000. Finally, 10Elms LLP purchased a new stake in Procter & Gamble during the fourth quarter worth $34,000. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Stock Performance
PG traded down $1.54 during midday trading on Friday, hitting $156.95. 8,051,886 shares of the company were exchanged, compared to its average volume of 7,607,817. The company's 50 day simple moving average is $161.77 and its 200 day simple moving average is $164.92. The firm has a market capitalization of $367.98 billion, a price-to-earnings ratio of 24.91, a price-to-earnings-growth ratio of 4.47 and a beta of 0.40. The company has a current ratio of 0.71, a quick ratio of 0.50 and a debt-to-equity ratio of 0.47. Procter & Gamble Company has a 1-year low of $155.95 and a 1-year high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, topping the consensus estimate of $1.53 by $0.01. The company had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The firm's revenue for the quarter was down 2.1% compared to the same quarter last year. During the same period last year, the firm earned $1.52 EPS. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.69%. The ex-dividend date of this dividend is Friday, July 18th. Procter & Gamble's dividend payout ratio is currently 67.14%.
Insider Activity
In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of the stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the sale, the insider directly owned 25,182 shares of the company's stock, valued at $3,995,627.94. This represents a 29.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jennifer L. Davis sold 1,000 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the sale, the chief executive officer directly owned 51,965 shares in the company, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
PG has been the subject of a number of analyst reports. Truist Financial lowered their target price on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating for the company in a report on Friday, April 25th. Evercore ISI restated an "outperform" rating and set a $190.00 target price (up previously from $170.00) on shares of Procter & Gamble in a report on Tuesday, June 3rd. JPMorgan Chase & Co. decreased their price objective on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating for the company in a report on Friday, April 11th. Piper Sandler increased their price objective on Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a report on Monday, May 5th. Finally, Redburn Atlantic lowered Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price objective for the company. in a report on Thursday, May 1st. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of "Moderate Buy" and an average target price of $178.45.
View Our Latest Research Report on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.